Discovery of ARS-1620 analogs as KRas G12C inhibitors with high in vivo antitumor activityHuiting Zhao, Jianjun Chen, Jingxuan Chen et al.|Bioorganic Chemistry|2022Cited by 14
Corrigendum to “Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity” [Bioorgan. Chem. 117 (2021) 105447]Ling Li, Chenglong Xu, Yinrong Wu et al.|Bioorganic Chemistry|2024Cited by 0